Damage to polymer of paclitaxel-eluting stent

Circulation Journal

Volumn 72, Issue 11, 2008, Pages 1907-1908

  Kitahara, Hideki ^a   Kobayashi, Yoshio ^a   Yamaguch, Masashi ^b   Ohkubo, Kenji ^a   Nakayama, Takashi ^a   Kuroda, Nakabumi ^a   Komuro, Issei ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

Angioplasty; Coronary artery disease; Restenosis; Stent

Indexed keywords

PACLITAXEL; POLYMER;

ADULT; ANAMNESIS; ARTERY CALCIFICATION; ARTERY CATHETERIZATION; ARTICLE; CASE REPORT; CORONARY ARTERY; DRUG DELIVERY SYSTEM; DRUG ELUTING STENT; HUMAN; INTRAVASCULAR ULTRASOUND; MALE; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CALCINOSIS; CORONARY RESTENOSIS; CORONARY VESSELS; DRUG-ELUTING STENTS; GRAFT OCCLUSION, VASCULAR; HUMANS; MALE; MIDDLE AGED; PACLITAXEL;

EID: 55449117540     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-08-0024     Document Type: Article

References (14)

1. Patterson C. Paclitaxel drug-eluting stents: The science behind the success. J Invasive Cardiol 2006; 18(Suppl F): 5F-10F.
2. Kuriyama N, Kobayashi Y, Nakayama T, Kuroda N, Komuro I. Damage to polymer of a sirolimus-eluting stent. Circulation 2006; 114: e586-e587.
3. Kitahara H, Kobayashi Y, Yamaguchi M, Fujimoto Y, Nameki M, Nakayama N, et al. Damage to polymer of undelivered sirolimus-eluting stents. J Invasive Cardiol 2008; 20: 130-133.
4. Ohtsuka Y, Chronos NAF, Apkarian RP, Robinson KA. Scanning electron microscopic analysis of defects in polymer coatings of three commercially available stents: Comparison of BiodivYsio, Taxus and Cypher. J Invasive Cardiol 2007; 19: 71-76.
5. Colombo A, Drzewiecki J, Banning A, Grube E, Hauptmann K, Silber S, et al. Randomized study to assess the effectiveness of slow-and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation 2003; 108: 788-794.
6. Ishio N, Kobayashi Y, Takebayashi H, Iijima Y, Kanda J, Nakayama T, et al. Impact of drug-eluting stents on clinical and angiographic outcomes in dialysis patients. Circ J 2007; 71: 1525-1529.
7. Fujii K, Mintz GS, Kobayashi Y, Carlier SG, Takebayashi H, Yasuda T, et al. Contribution of stent underexpansion to recurrence after sirolimus-eluting stent implantation for in-stent restenosis. Circulation 2004; 109: 1085-1088.
8. Lee SH, Park JS, Shin DG, Kim YJ, Hong GR, Kim W, et al. Frequency of stent fracture as a cause of coronary restenosis after sirolimus-eluting stent implantation. Am J Cardiol 2007; 100: 627-630.
9. Takebayashi H, Mintz GS, Carlier SG, Kobayashi Y, Fujii K, Yasuda T, et al. Non-uniform strut distribution correlates with more neointimal hyperplasia after sirolimus-eluting stent implantation. Circulation 2004; 110: 3430-3434.
10. Colombo A, Orlic D, Stankovic G, Corvaja N, Spanos V, Montorfano M, et al. Preliminary observations regarding angiographic pattern of restenosis after rapamycin-eluting stent implantation. Circulation 2003; 107: 2178-2180.
11. Suzuki T, Kopia G, Hayase S, Bailey LR, Llanos G, Wilensky R, et al. Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary artery. Circulation 2001; 104: 1188-1193.
12. Schampaert E, Cohen EA, Schluter M, Reeves F, Traboulsi M, Title LM, et al. The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS). J Am Coll Cardiol 2004; 43: 1110-1115.
13. Jafary FH. When one won't do it, use two-double "buddy" wiring to facilitate stent advancement across a highly calcified artery. Catheter Cardiovasc Interv 2006; 67: 721-723.
14. Singh A, Awar M, Ahmed A, Fischman DL, Walinsky P, Savage MP. Facilitated stent delivery using applied topical lubrication. Catheter Cardiovasc Interv 2007; 69: 218-222.